Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041759 | SCV000065455 | benign | not specified | 2011-12-16 | criteria provided, single submitter | clinical testing | Ala4778Asp in exon 65 of USH2A: This variant is not expected to have clinical si gnificance because it has been identified in 2.7% (100/3738) of chromosomes from a broad African American population (dbSNP rs146994147). |
ARUP Laboratories, |
RCV000755429 | SCV000605553 | benign | not provided | 2017-05-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000755429 | SCV000730481 | benign | not provided | 2019-02-28 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 20507924) |
Labcorp Genetics |
RCV000755429 | SCV001027318 | benign | not provided | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450792 | SCV004183075 | benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001826592 | SCV004183076 | benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000755429 | SCV005287597 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001826592 | SCV002088229 | benign | Usher syndrome type 2A | 2019-12-07 | no assertion criteria provided | clinical testing |